Skip to main content
Erschienen in: Current Urology Reports 9/2014

01.09.2014 | Urothelial Cancer (A Sagalowsky, Section Editor)

Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?

verfasst von: Stephanie P. Chen, Joseph C. Liao

Erschienen in: Current Urology Reports | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Urothelial carcinoma of the bladder and upper tract pose significant diagnostic and therapeutic challenges. White light endoscopy plays a central role in the management of urothelial carcinoma but has several well-recognized shortcomings. New optical imaging technologies may improve diagnostic accuracy, enhance local cancer control, and better stratify treatment options. Confocal laser endomicroscopy enables dynamic imaging of the cellular structures below the mucosal surface and holds promise in providing real time optical diagnosis and grading of urothelial carcinoma. A variety of imaging probes are available that are compatible with the full spectrum of cystoscopes and ureteroscopes. We review the underlying principles and technique of confocal laser endomicroscopy in the urinary tract, with emphasis on specific application towards urothelial carcinoma. While the available data are largely related to urothelial carcinoma of the bladder, the lessons learned are directly applicable to the upper tract, where the clinical needs are significant. Ongoing efforts to optimize this technology offer an exciting glimpse into future advances in optical imaging and intraoperative image guidance.
Literatur
1.
Zurück zum Zitat U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 incidence and mortality web-based report. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2013). U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 incidence and mortality web-based report. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2013).
2.
3.
Zurück zum Zitat Kirkali Z et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66:4–34.PubMedCrossRef Kirkali Z et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66:4–34.PubMedCrossRef
5.
Zurück zum Zitat Sylvester RJ et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–77.PubMedCrossRef Sylvester RJ et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–77.PubMedCrossRef
6.
Zurück zum Zitat Cauberg Evelyne CC, de la Rosette JJMCH, de Reijke TM. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol IJU J Urol Soc India. 2011;27:245–51.CrossRef Cauberg Evelyne CC, de la Rosette JJMCH, de Reijke TM. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol IJU J Urol Soc India. 2011;27:245–51.CrossRef
7.
Zurück zum Zitat Rouprêt M et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRef Rouprêt M et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRef
8.
Zurück zum Zitat Hall MC et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594–601.PubMedCrossRef Hall MC et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594–601.PubMedCrossRef
9.
Zurück zum Zitat Linton KD, Catto JW. Upper tract urothelial carcinoma. J Clin Urol. 2013;6:272–9. Linton KD, Catto JW. Upper tract urothelial carcinoma. J Clin Urol. 2013;6:272–9.
10.
Zurück zum Zitat Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:130–6.PubMedCrossRef Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:130–6.PubMedCrossRef
11.
Zurück zum Zitat Lee CSD, Yoon CY, Witjes JA. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. BJU Int. 2008;102:1228–33.PubMedCrossRef Lee CSD, Yoon CY, Witjes JA. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. BJU Int. 2008;102:1228–33.PubMedCrossRef
12.
13.•
Zurück zum Zitat Wu K et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology. 2011;78:225–31. This paper describes the suggested optical diagnostic criteria for normal urothelium, benign inflammatory urothelium, low grade urothelial carcinoma, and high grade urothelial carcinoma.PubMedCentralPubMedCrossRef Wu K et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology. 2011;78:225–31. This paper describes the suggested optical diagnostic criteria for normal urothelium, benign inflammatory urothelium, low grade urothelial carcinoma, and high grade urothelial carcinoma.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Schmidbauer J et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171:135–8.PubMedCrossRef Schmidbauer J et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171:135–8.PubMedCrossRef
15.
Zurück zum Zitat Fradet Y et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178:68–73. discussion 73.PubMedCrossRef Fradet Y et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178:68–73. discussion 73.PubMedCrossRef
16.
Zurück zum Zitat Jocham D et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174:862–6. discussion 866.PubMedCrossRef Jocham D et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174:862–6. discussion 866.PubMedCrossRef
17.
Zurück zum Zitat Kolozsy Z. Histopathological ‘self control’ in transurethral resection of bladder tumours. Br J Urol. 1991;67:162–4.PubMedCrossRef Kolozsy Z. Histopathological ‘self control’ in transurethral resection of bladder tumours. Br J Urol. 1991;67:162–4.PubMedCrossRef
18.
Zurück zum Zitat Babjuk M, Soukup V, Petrík R, Jirsa M, Dvorácek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96:798–802.PubMedCrossRef Babjuk M, Soukup V, Petrík R, Jirsa M, Dvorácek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96:798–802.PubMedCrossRef
19.
Zurück zum Zitat Daniltchenko DI et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174:2129–33. discussion 2133.PubMedCrossRef Daniltchenko DI et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174:2129–33. discussion 2133.PubMedCrossRef
20.
Zurück zum Zitat Klän R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146:316–8.PubMed Klän R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146:316–8.PubMed
21.
Zurück zum Zitat Brausi M et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–31.PubMedCrossRef Brausi M et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–31.PubMedCrossRef
22.
Zurück zum Zitat Margulis V et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33.PubMedCrossRef Margulis V et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33.PubMedCrossRef
23.
Zurück zum Zitat Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1166–70.PubMedCrossRef Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1166–70.PubMedCrossRef
24.
Zurück zum Zitat Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012;79:615–9.PubMedCrossRef Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012;79:615–9.PubMedCrossRef
25.
Zurück zum Zitat Smith AK et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–6.PubMedCrossRef Smith AK et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–6.PubMedCrossRef
26.
Zurück zum Zitat Tavora F et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.PubMedCrossRef Tavora F et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.PubMedCrossRef
27.
Zurück zum Zitat Cutress ML et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110:614–28.PubMedCrossRef Cutress ML et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110:614–28.PubMedCrossRef
28.
Zurück zum Zitat Elliott DS, Segura JW, Lightner D, Patterson DE, Blute ML. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.PubMedCrossRef Elliott DS, Segura JW, Lightner D, Patterson DE, Blute ML. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.PubMedCrossRef
29.
Zurück zum Zitat Gadzinski AJ, Roberts WW, Faerber GJ, Wolf Jr JS. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol. 2010;183:2148–53.PubMedCrossRef Gadzinski AJ, Roberts WW, Faerber GJ, Wolf Jr JS. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol. 2010;183:2148–53.PubMedCrossRef
30.
Zurück zum Zitat Lopez A, Liao JC. Emerging endoscopic imaging technologies for bladder cancer detection. Curr Urol Rep. 2014;15:406.PubMedCrossRef Lopez A, Liao JC. Emerging endoscopic imaging technologies for bladder cancer detection. Curr Urol Rep. 2014;15:406.PubMedCrossRef
31.•
Zurück zum Zitat Sonn GA et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182:1299–305. This paper was the initial feasibility study of in vivo confocal laser endomicroscopy in the urinary tract.PubMedCrossRef Sonn GA et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182:1299–305. This paper was the initial feasibility study of in vivo confocal laser endomicroscopy in the urinary tract.PubMedCrossRef
32.
Zurück zum Zitat Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139:388–92. 392.e1–2.PubMedCrossRef Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139:388–92. 392.e1–2.PubMedCrossRef
33.
Zurück zum Zitat Thiberville L, Salaün M. Bronchoscopic advances: on the way to the cells. Respir Int Rev Thorac Dis. 2010;79:441–9. Thiberville L, Salaün M. Bronchoscopic advances: on the way to the cells. Respir Int Rev Thorac Dis. 2010;79:441–9.
34.
Zurück zum Zitat Sonn GA et al. Fibered confocal microscopy of bladder tumors: an ex vivo study. J Endourol Endourol Soc. 2009;23:197–201.CrossRef Sonn GA et al. Fibered confocal microscopy of bladder tumors: an ex vivo study. J Endourol Endourol Soc. 2009;23:197–201.CrossRef
35.•
Zurück zum Zitat Chang TC, Liu J-J, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;e4409. doi:10.3791/4409. This on-line video paper demonstrates a step-by-step approach of confocal laser endomicroscopy in the lower urinary tract. Chang TC, Liu J-J, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;e4409. doi:10.​3791/​4409. This on-line video paper demonstrates a step-by-step approach of confocal laser endomicroscopy in the lower urinary tract.
36.
Zurück zum Zitat Wallace MB et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 2010;31:548–52.PubMedCrossRef Wallace MB et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 2010;31:548–52.PubMedCrossRef
37.
Zurück zum Zitat Becker V et al. High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). Gastrointest Endosc. 2007;66:1001–7.PubMedCrossRef Becker V et al. High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). Gastrointest Endosc. 2007;66:1001–7.PubMedCrossRef
38.•
Zurück zum Zitat Chang TC et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol Endourol Soc. 2013;27:598–603. This paper describes the interobserver agreement of confocal laser endomicroscopy of bladder lesions and provides an updated optical diagnostic criteria.CrossRef Chang TC et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol Endourol Soc. 2013;27:598–603. This paper describes the interobserver agreement of confocal laser endomicroscopy of bladder lesions and provides an updated optical diagnostic criteria.CrossRef
39.
Zurück zum Zitat Aron M et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol. 2013;37:1815–23.PubMedCrossRef Aron M et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol. 2013;37:1815–23.PubMedCrossRef
40.
Zurück zum Zitat Wallace MB et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett’s esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc. 2010;72:19–24.PubMedCentralPubMedCrossRef Wallace MB et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett’s esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc. 2010;72:19–24.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed
42.
Zurück zum Zitat Kuiper T, Kiesslich R, Ponsioen C, Fockens P, Dekker E. The learning curve, accuracy, and interobserver agreement of endoscope-based confocal laser endomicroscopy for the differentiation of colorectal lesions. Gastrointest Endosc. 2012;75:1211–7.PubMedCrossRef Kuiper T, Kiesslich R, Ponsioen C, Fockens P, Dekker E. The learning curve, accuracy, and interobserver agreement of endoscope-based confocal laser endomicroscopy for the differentiation of colorectal lesions. Gastrointest Endosc. 2012;75:1211–7.PubMedCrossRef
43.
Zurück zum Zitat Gómez V et al. Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy. 2010;42:286–91.PubMedCrossRef Gómez V et al. Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy. 2010;42:286–91.PubMedCrossRef
44.
Zurück zum Zitat Lee YC et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.PubMedCentralPubMedCrossRef Lee YC et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Kiesslich R et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006;4:979–87. Kiesslich R et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006;4:979–87.
46.
Zurück zum Zitat Gaddam S et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2011;106:1961–9.PubMedCrossRef Gaddam S et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2011;106:1961–9.PubMedCrossRef
47.
Zurück zum Zitat Bui D, Mach KE, Lopez A, Liu JJ, Chang T, Lavelle J, et al. Optical biopsy of upper tract urothelial carcinoma with confocal laser endomicroscopy. Eur Urol. 2014;13:e630.CrossRef Bui D, Mach KE, Lopez A, Liu JJ, Chang T, Lavelle J, et al. Optical biopsy of upper tract urothelial carcinoma with confocal laser endomicroscopy. Eur Urol. 2014;13:e630.CrossRef
48.
Zurück zum Zitat André B, Vercauteren T, Buchner AM, Wallace MB, Ayache N. A smart atlas for endomicroscopy using automated video retrieval. Med Image Anal. 2011;15:460–76.PubMedCrossRef André B, Vercauteren T, Buchner AM, Wallace MB, Ayache N. A smart atlas for endomicroscopy using automated video retrieval. Med Image Anal. 2011;15:460–76.PubMedCrossRef
49.
Zurück zum Zitat André B et al. Software for automated classification of probe-based confocal laser endomicroscopy videos of colorectal polyps. World J Gastroenterol WJG. 2012;18:5560–9.CrossRef André B et al. Software for automated classification of probe-based confocal laser endomicroscopy videos of colorectal polyps. World J Gastroenterol WJG. 2012;18:5560–9.CrossRef
50.
51.
Zurück zum Zitat Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol. 2001;19:327–31.PubMedCrossRef Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol. 2001;19:327–31.PubMedCrossRef
52.
Zurück zum Zitat Sturm MB et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med. 2013;5:184ra61.PubMedCrossRef Sturm MB et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med. 2013;5:184ra61.PubMedCrossRef
53.
Zurück zum Zitat Miller SJ et al. In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe. PLoS One. 2011;6:e17384.PubMedCentralPubMedCrossRef Miller SJ et al. In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe. PLoS One. 2011;6:e17384.PubMedCentralPubMedCrossRef
54.
Zurück zum Zitat Thekkek N et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett’s-associated neoplasia during confocal imaging. Technol Cancer Res Treat. 2011;10:431–41.PubMedCentralPubMed Thekkek N et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett’s-associated neoplasia during confocal imaging. Technol Cancer Res Treat. 2011;10:431–41.PubMedCentralPubMed
Metadaten
Titel
Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?
verfasst von
Stephanie P. Chen
Joseph C. Liao
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 9/2014
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0437-y

Weitere Artikel der Ausgabe 9/2014

Current Urology Reports 9/2014 Zur Ausgabe

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

A Review of Lower Urinary Tract Symptoms in Patients with Parkinson’s Disease

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Bladder Outlet Obstruction in Women: Functional Causes

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Evaluation and Management of Post-Transurethral Resection of the Prostate Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

UTIs in Patients with Neurogenic Bladder

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

The Evaluation and Management of Persistent Nocturia

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Management of Refractory OAB in the Non-Neurogenic Patient

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.